anaphore inc
Anaphore Acquires Shanghai-Based RuiYi For Biologics Drug Discovery Platform
Anaphore Inc. has acquired Shanghai-based RuiYi Inc., a company that develops small molecule drugs targeting G protein coupled receptors.
Anaphore Inc. has acquired Shanghai-based RuiYi Inc., a company that develops small molecule drugs targeting G protein coupled receptors.
